Deletion Mapping of Chromosome 1p and 22q in Pheochromocytoma

od Shin, Eisei, Fujita, Shoichi, Takami, Koji, Kurahashi, Hiroki, Kurita, Yoshihiro, Kobayashi, Tetsuro, Mori, Takesada, Nishisho, Isamu, Takai, Shin‐ichiro
izdano v Jpn J Cancer Res (1993)

Inactivation of the p53 Gene Is not Required for Tumorigenesis of Medullary Thyroid Carcinoma or Pheochromocytoma

od Yana, Ikuo, Nakamura, Tsutomu, Shin, Eisei, Karakawa, Katsu, Kurahashi, Hiroki, Kurita, Yoshihiro, Kobayashi, Tetsuro, Mori, Takesada, Nishisho, Isamu, Takai, Shin‐ichiro
izdano v Jpn J Cancer Res (1992)

p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid Carcinomas

od Nakamura, Tsutomu, Yana, Ikuo, Kobayashi, Tetsuro, Shin, Eisei, Karakawa, Katsu, Fujita, Shoichi, Miya, Akihiro, Mori, Takesada, Nishisho, Isamu, Takai, Shin‐ichiro
izdano v Jpn J Cancer Res (1992)

Phase 3, open-label, randomized study comparing 3-monthly with monthly goserelin in pre-menopausal women with estrogen receptor-positive advanced breast cancer

od Noguchi, Shinzaburo, Kim, Hee Jeong, Jesena, Anita, Parmar, Vani, Sato, Nobuaki, Wang, Hwei-Chung, Lokejaroenlarb, Santi, Isidro, Jofel, Kim, Ku Sang, Itoh, Yohji, Shin, Eisei
izdano v Breast Cancer (2015)

Real‐world outcomes of chemoradiotherapy for unresectable Stage III non‐small cell lung cancer: The SOLUTION study

od Horinouchi, Hidehito, Atagi, Shinji, Oizumi, Satoshi, Ohashi, Kadoaki, Kato, Tomohiro, Kozuki, Toshiyuki, Seike, Masahiro, Sone, Takashi, Sobue, Tomotaka, Tokito, Takaaki, Harada, Hideyuki, Maeda, Tadashi, Mio, Tadashi, Shirosaka, Ikue, Hattori, Kana, Shin, Eisei, Murakami, Haruyasu
izdano v Cancer Med (2020)